Precision BioSciences' mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences. Precision's proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
Adage Capital Management
Alexandria Real Estate Equities
Cormorant Asset Management
Osage University Partners
Ridgeback Capital Management